Mouna Tababi
Forskningsingenjör
Publikationer
2026
Integrative Epigenomic and Transcriptomic Profiling Define Malignancy- and Cluster-Specific Signatures in Pheochromocytomas and Paragangliomas
Cells, Vol. 15, Artikel 198
(Artikel i tidskrift)
https://dx.doi.org/10.3390/cells15020198
2025
Role of GDH and PARP inhibitors as novel treatments for SDHB-deficient PPGLs
Endocrine-Related Cancer, Vol. 32, Artikel e250173
(Artikel i tidskrift)
https://dx.doi.org/10.1530/ERC-25-0173
Rab7 inhibitor enhances stem cell differentiation into keratinocyte-like cells with anti-inflammatory properties
Frontiers in Immunology, Vol. 16, Artikel 1503007
(Artikel i tidskrift)
https://dx.doi.org/10.3389/fimmu.2025.1503007
2023
Nuclear and mitochondrial DNA alterations in pheochromocytomas and paragangliomas, and their potential treatment
Endocrine-Related Cancer, Vol. 30, Artikel e220217
(Artikel, forskningsöversikt)
https://dx.doi.org/10.1530/ERC-22-0217
Domain landscapes of somatic NF1 mutations in pheochromocytoma and paraganglioma
Gene, Vol. 872, Artikel 147432
(Artikel i tidskrift)
https://dx.doi.org/10.1016/j.gene.2023.147432